A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

Clinical trial NCT07239466 · RECRUITING

Trial details

NCT number: NCT07239466
Sponsor: Tao Zhang
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Cancer Radiotherapy Immunotherapy Chemotherapy

Start date: 2026-01-01
Primary completion: 2026-12-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.